Øyvind Kongstun Arnesen

Chairman of the Board

A black and white portrait of an older man with short hair and glasses. He is wearing a checkered blazer over a button-down shirt with an open collar, projecting a smart, professional appearance. The man is smiling slightly and looking directly at the camera, giving a warm and approachable impression. The background is plain and white, ensuring all focus is on the subject.

Øyvind Kongstun Arnesen was appointed chairman of the board in 2018.

Kongstun Arnesen is a Medical Doctor with more than ten years of clinical experience and extensive experience from the Pharmaceutical Industry holding positions as Medial Director Bristol-Myers Squibb B, Medical Director, and Head of Clinical Operations at Boehringer Ingelheim and CEO of Ultimovacs from 2012 to 2020. From 2010 to 2021 he served as member of the National Commision for Investigation of Research Misconduct.

He is Chairman of the Board in Hubro Therapeutics and works as an independent advisor to Radforsk, Canica and other investors in the life science sector.